Credit:FDASM.comFriday, November 13, 2009
HF Exclusive: From the Floor of the FDA Social Media Hearing
After this morning’s lively discussion on adverse event reporting, the Ruder Finn senior staff provides another look at the unfolding conversations at this week’s FDA public hearing on the use of social media by the pharmaceutical industry:
When discussing the proposed adjustments to online adverse events (AE) reporting, it’s important to define current FDA guidelines on 
Filed under: Drugs, FDA
by
admin
at 1:37 pm 11.13.09
Keywords: FDASM, Health 2.0
Credit:FDASM.comFriday, November 13, 2009
FDASM: Google’s Pitch to FDA for Online Drug Ads
By Jacob Goldstein, WSJ Health Blog
Sure, dozens of groups are speaking at this week’s FDA meeting on online advertising for drugs and medical devices.
But we’re particularly interested in what Google had to say, given the company’s 800-pound-gorilla status in online advertising — as well as the flurry of FDA warning letters earlier this year
Filed under: Drugs, FDA, Weekly Round Up
by
admin
at 11:33 am 11.13.09
Keywords: FDASM, Health 2.0
Credit:FDASM.comFriday, November 13, 2009
FDASM: Day One in DC: Industry bends FDA’s ear on social media
By Matthew Arnold, Medical Marketing & Media
The FDA’s hearings on promotion of regulated products online and using social media—the “Super Bowl of Part 15 Hearings,” as Porter Novelli’s Peter Pitts dubbed them—got under way yesterday in a near-capacity federal conference hall. More than 800 people had tried to register, said DDMAC director Thomas Abrams, and
Filed under: Drugs, FDA, Weekly Round Up
by
admin
at 11:31 am 11.13.09
Keywords: FDASM, Health 2.0
Credit:FDASM.comFriday, November 13, 2009
FDASM: Drug ads get FDA scrutiny
By Kim Hart, The Hill
When patients are diagnosed with an illness or prescribed a new medication, the Web is fast becoming the first place they look for information, support groups and treatment options.
Drug companies want to be part of that conversation. But they are wary of advertising online because of the Food and Drug Adminstration’s
Filed under: Drugs, FDA, Weekly Round Up
by
admin
at 11:28 am 11.13.09
Keywords: FDASM, Health 2.0
Credit:FDASM.comFriday, November 13, 2009
HF Exclusive: From the Floor of the FDA Social Media Hearing
Yesterday’s session covered a range of issues as presented by key players from industry and third party executives: topics ranged from proposals that manufacturers be held accountable for everything posted online relating to their products to multiple pleas to consider the value this unique medium can play in proper education of consumers and physicians alike.
Topics
Filed under: Drugs, FDA
by
admin
at 10:07 am 11.13.09
Keywords: FDASM, Health 2.0
